ArticleHuman mutation2020

Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines.

Cristina Fortuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.